Similarly, as previously reported [29], c-Src lies upstream of ERK and Akt, which suggests that Cbl-b inhibited RANKL-induced breast cancer cell migration via the c-Src/Akt and c-Src/ERK pathways. This evidence concerns the gene CBLB and breast carcinoma.